On Wednesday, Robert F. Kennedy Jr. goes to Capitol Hill to promote and defend his massive overhaul of HHS, and President Trump's plans to change it even more.
The unexpected elimination of funding for the decades-long research project focused on women's health shocked scientists. They were heartened by the quick restoration of support.
House Rep. Gerry Connolly is pushing CDC leadership to explain why the personnel who handle FOIA requests lost their jobs, noting that that the public has a right to access federal records.
An independent vaccine advisory committee to the Centers for Disease Control and Prevention met to discuss and vote on vaccine policy for the first time since the change in administrations.
Federal funding cuts, though temporarily blocked by a judge, have upended vaccination outreach across the country, including in Arizona, Minnesota, Nevada, Texas, and Washington state.
Health agency staffers describe a week of widespread uncertainty about who still has a job and how the work will get done as thousands of "reduction in force" notices went out beginning April 1. To many it's the opposite of "government efficiency."
Federal health agencies have to slash their spending on contracts by more than a third, on top of the 10,000-person staffing cuts which started this week.
Despite promises for "radical transparency," Health and Human Services Secretary Robert F. Kennedy Jr. laid off many staff on teams that fulfill public records requests at health agencies.
Dr. Dave Weldon, Trump's pick for director of the Centers for Disease Control and Prevention, was withdrawn from consideration shortly before a scheduled Senate confirmation hearing.
Dr. Jay Bhattacharya, a Stanford professor of health policy, appears before the Senate HELP committee, which will vet his nomination to become the next director of the National Institutes of Health.
Dr. Mehmet Oz, nominated to run the Centers for Medicare & Medicaid Services, will sell shares in Eli Lilly and UnitedHealth. Dr. Jay Bhattacharya, NIH nominee, will shed stock in Walmart and Nvidia.
The panel of vaccine experts were supposed to hold their first meeting under the Trump administration in late February. It's not clear when that meeting will now take place.
